glp 1 late period Timeline of GLP-1 discovery and clinical development. (a) Key events in Reconciling GLP-1s and Pancreatitis

Abrahamsson N, Engstrom BE, Sundbom M, Karlsson FA

While the less frequent subcutaneous dosing (once-weekly vs liraglutide's once-daily subcutaneous injection) or the daily oral intake of tablets may seem appealing, there is a lack of RCT data regarding the effects of these compounds on BAD symptoms

This article examines the safety considerations, mechanisms of action, potential interactions, side effects, and essential discussions to have with your GP before taking these medications concurrently

The most frequently reported AEs were gastrointestinal in nature, with nausea, vomiting, and diarrhea being the most common

J Toxicol Environ Health

Weight loss injection drugs mimic the effects of GLP-1